An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.
| Autor: | Raje, Noopur 1, Richardson, Paul 2, Hari, Parameswaran N 3, Mahindra, Anuj 1, Kaster, Sarah *, 1, Connolly, Christine *, 1, Rivera, Linda *, 1, Chetri, Gaurav *, 1, Dean, Sarah *, 2, Jacobs, Paulette *, 3, Saad, Ayman 3, Laubach, Jacob *, 2, Ghobrial, Irene M. 2, Schlossman, Robert L 2, Adams, Jennifer *, 4, Makrides, Wendy *, 5, Weller, Edie *, 2, Munshi, Nikhil 2, Anderson, Kenneth C. 2 |
|---|---|
| Zdroj: | In Blood 20 November 2009 114(22):3856-3856 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|